Ganjiang Chinese Medicine Innovation Center, Nanchang, China.
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, United States.
Front Immunol. 2023 Nov 16;14:1254446. doi: 10.3389/fimmu.2023.1254446. eCollection 2023.
GPR35 is a G protein-coupled receptor with notable involvement in modulating inflammatory responses. Although the precise role of GPR35 in inflammation is not yet fully understood, studies have suggested that it may have both pro- and anti-inflammatory effects depending on the specific cellular environment. Some studies have shown that GPR35 activation can stimulate the production of pro-inflammatory cytokines and facilitate the movement of immune cells towards inflammatory tissues or infected areas. Conversely, other investigations have suggested that GPR35 may possess anti-inflammatory properties in the gastrointestinal tract, liver and certain other tissues by curbing the generation of inflammatory mediators and endorsing the differentiation of regulatory T cells. The intricate role of GPR35 in inflammation underscores the requirement for more in-depth research to thoroughly comprehend its functional mechanisms and its potential significance as a therapeutic target for inflammatory diseases. The purpose of this review is to concurrently investigate the pro-inflammatory and anti-inflammatory roles of GPR35, thus illuminating both facets of this complex issue.
GPR35 是一种 G 蛋白偶联受体,在调节炎症反应方面具有显著作用。尽管 GPR35 在炎症中的确切作用尚未完全阐明,但研究表明,它可能具有促炎和抗炎作用,具体取决于特定的细胞环境。一些研究表明,GPR35 的激活可以刺激促炎细胞因子的产生,并促进免疫细胞向炎症组织或感染区域移动。相反,其他研究表明,GPR35 可能通过抑制炎症介质的产生和促进调节性 T 细胞的分化,在胃肠道、肝脏和某些其他组织中具有抗炎特性。GPR35 在炎症中的复杂作用强调了需要进行更深入的研究,以彻底了解其功能机制及其作为炎症性疾病治疗靶点的潜在意义。本综述的目的是同时研究 GPR35 的促炎和抗炎作用,从而阐明这个复杂问题的两个方面。